Inactive Instrument

Insiders Flexion Therapeutics, Inc.

Equities

FLXN

US33938J1060

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Renovacor Names New CFO	22-03-28	MT
Flexion Therapeutics, Inc. Announces Resignation of Patrick Mahaffy as A Member and Chair of the Audit Committee	21-07-12	CI
Flexion Therapeutics, Inc. Announces Appointment of Utpal Koppikar to Board of Directors	21-07-12	CI
Flexion Therapeutics, Inc. Appoints William T. Andrews as Chief Medical Officer, Effective July 1, 2021	21-06-09	CI
Flexion Therapeutics, Inc. Appoints Frederick W. Driscoll as Principal Financial Officer, and Principal Accounting Officer	21-05-12	CI
Flexion Therapeutics, Inc. Announces the Resignation of Dr. Scott Kelley as Chief Medical Officer, Effective in May 2021	21-04-05	CI
Flexion Therapeutics, Inc. Announces Board Changes	21-03-10	CI
Flexion Therapeutics, Inc. Announces Resignation of Sandesh Mahatme from the Board of Directors	20-11-19	CI
Flexion Therapeutics Announces Appointment of Elizabeth Liz Kwo, to Board of Directors	20-08-19	CI
Flexion Therapeutics Names Melissa Layman Chief Commercial Officer	20-03-11	CI
Flexion Therapeutics Announces the Retirement of Neil Bodick, Chief Scientific Officer, Effective January 3, 2020	19-12-10	CI
Flexion Therapeutics Named one of Boston Business Journal’s Best Places to Work for the Third Consecutive Year	19-06-20	GL
Flexion Therapeutics Announces Kerry Wentworth, Chief Regulatory Officer, Appointed to Massachusetts Biotechnology Council Board	19-04-01	GL
Flexion Therapeutics, Inc. Names Christina Willwerth as Chief Strategy Officer	19-01-22	CI
Flexion Therapeutics : Named Top Place to Work for Second Consecutive Year by The Boston Globe	18-11-16	PU
Flexion Therapeutics Named Top Place to Work for Second Consecutive Year by The Boston Globe	18-11-16	GL
Flexion Therapeutics Named one of Boston Business Journal’s Best Places to Work for the Second Year in a Row	18-06-21	GL
Flexion Therapeutics, Inc. Announces Management Changes	18-05-07	CI
Flexion Therapeutics, Inc. Announces Chief Medical Officer Changes	17-12-11	CI
Flexion Therapeutics, Inc. Appoints Mark Levine as Senior Vice President, General Counsel and Secretary	17-06-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Flexion Therapeutics, Inc.

Equities

FLXN

US33938J1060

Insiders

Filters